BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications

  Soligenix, Inc. announced that the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, has awarded Soligenix a Phase I Small Business Innovation Research of approximately $150,000 to support the evaluation of SGX942 in pediatric indications.

  August 15, 2019

   · 

  10 min read
• Novasec Funds the Future with New Renewable Energy Investment Platform

  Novasec’s platform combines the renewable energy sector with digital securities, providing investors the potential for lower-risk, competitive returns.

  August 15, 2019

   · 

  2 min read
• Business

  Priority Private Care Rebrands As Sollis Heath

  The members-only 24/7 medical centers and concierge service relaunch with a new identity and a new look

  August 15, 2019

   · 

  1 min read
• Business

  Foundry Treatment Center In Steamboat Springs Announces Partnership With Renown Industry Veteran Ben Cort

  One of the country’s premier, trauma-integrated men’s treatment facilities, Foundry Treatment Center Steamboat, announces a partnership with accomplished recovery professional Ben Cort of Cort Consulting.

  August 15, 2019

   · 

  3 min read
• BioMidwest

  ViewRay® to Participate in Upcoming Investor Conferences

  ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in two upcoming investor conferences in New York, NY.

  August 15, 2019

   · 

  1 min read
• FDA

  Harmony Biosciences Announces FDA Approval Of WAKIX® (Pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

  Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and Drug Administration (FDA) approved WAKIX® (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy

  August 15, 2019

   · 

  6 min read
• Global Gallbladder Cancer Therapeutics Market 2019-2023 | Advent of Targeted Therapy to Boost Growth | Technavio

  The global gallbladder cancer therapeutics market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report by Technavio.

  August 15, 2019

   · 

  4 min read
• Dietary Choline Associates With Reduced Risk of Dementia

  A new study by researchers at the University of Eastern Finland is the first to observe that dietary intake of phosphatidylcholine is associated with a reduced risk of dementia.

  August 15, 2019

   · 

  3 min read
• Business

  Calliditas Therapeutics: Interim Report Q2, 2019

  Large China deal further validates Nefecon market potential

  August 15, 2019

   · 

  4 min read